1-Year Outcomes of the CENTERA-EU Trial Assessing a Novel Self-Expanding Transcatheter Heart Valve
Didier Tchétché, Stephan Windecker, A. Markus Kasel, Ulrich Schaefer, Stephen Worthley, Axel Linke, Mohamed Abdel-Wahab, Herve Le Breton, Lars Søndergaard, Mark S. Spence, Sonia Petronio, Helmut Baumgartner, Tomas Hovorka, Philipp Blanke and Hermann Reichenspurner
(A) Changes in mean aortic valve gradient (MAVG) and effective orifice area (EOA). The line graph shows changes in the MAVG (blue) and EOA (red) of patients at baseline, discharge, and 1 year. Error bars represent SD. (B) Aortic regurgitation at discharge and to 1 year. For MAVG and EOA, the p value is <0.001 for all visits compared with baseline, based on a 2-sided paired t-test with the null hypothesis that there is no change from baseline (paired analysis).